🇰🇷 Topicort in South Korea

MFDS authorised Topicort on 28 February 1977

Marketing authorisation

MFDS — authorised 28 February 1977

  • Marketing authorisation holder: TARO PHARMS NORTH
  • Status: likely_approved

Topicort in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in South Korea

Frequently asked questions

Is Topicort approved in South Korea?

Yes. MFDS authorised it on 28 February 1977.

Who is the marketing authorisation holder for Topicort in South Korea?

TARO PHARMS NORTH holds the South Korean marketing authorisation.